Original Research

Published on 18 Aug 2022

Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis

in Hematologic Malignancies

Zhe Zhuang
Yan Zhang
Xiao Zhang
Meifen Zhang
Dongmei Zou
Li Zhang
Congwei Jia
Wei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.955080

2,386 views
6 citations

Brief Research Report

Published on 17 Aug 2022

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis

in Hematologic Malignancies

Michael Stadler
Letizia Venturini
Ivonne Bünting
Elke Dammann
Eva M. Weissinger
Adrian Schwarzer
Christian Schultze-Florey
Steve Ehrlich
Dominik Markel
Catherina Lueck

Frontiers in Oncology

doi 10.3389/fonc.2022.867356

1,876 views
6 citations

Brief Research Report

Published on 17 Aug 2022

Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia

in Hematologic Malignancies

Adrián Mosquera Orgueira
Andrés Peleteiro Raíndo
José Ángel Díaz Arias
Beatriz Antelo Rodríguez
Mónica López Riñón
Claudio Cerchione
Adolfo de la Fuente Burguera
Marta Sonia González Pérez
Giovanni Martinelli
Pau Montesinos Fernández

Frontiers in Oncology

doi 10.3389/fonc.2022.968340

2,012 views
2 citations

Original Research

Published on 17 Aug 2022

Post-chemotherapy pneumonia in Chinese patients with diffuse large B-cell lymphoma: Outcomes and predictive model

in Hematologic Malignancies

Jinrong Zhao
Yan Zhang
Wei Wang
Wei Zhang
Daobin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.955535

1,698 views

Brief Research Report

Published on 16 Aug 2022

Whole transcriptome sequencing reveals a TCF4-ZNF384 fusion in acute lymphoblastic leukemia

in Hematologic Malignancies

Zhengyu Wu
Fang Zhang
Chengzhu Liu
Shuhong Shen
Jinhua Chu
Linhai Yang
Zhiwei Xie
Yu Liu
Kangkang Liu
Ningling Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.900054

2,207 views
1 citation

Review

Published on 16 Aug 2022

Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy

in Hematologic Malignancies

Valeria Ferla
Elena Antonini
Tommaso Perini
Francesca Farina
Serena Masottini
Simona Malato
Sarah Marktel
Maria Teresa Lupo Stanghellini
Cristina Tresoldi
Fabio Ciceri

Frontiers in Oncology

doi 10.3389/fonc.2022.932852

9,184 views
8 citations

Review

Published on 12 Aug 2022

Small but strong: Pivotal roles and potential applications of snoRNAs in hematopoietic malignancies

in Hematologic Malignancies

Jian Dong
Hui Wang
Zhaoru Zhang
Lin Yang
Xinyue Qian
Wenchang Qian
Yingli Han
He Huang
Pengxu Qian

Frontiers in Oncology

doi 10.3389/fonc.2022.939465

3,125 views
8 citations

Editorial

Published on 10 Aug 2022

Editorial: Global excellence in oncology: Asia and Australia 2021

in Hematologic Malignancies

Kun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.980419

1,750 views

Original Research

Published on 10 Aug 2022

Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: A report from the South China Children’s Leukemia Group

in Hematologic Malignancies

Lu-Hong Xu
Xu Geng
Ning Liao
Li-Hua Yang
Hui-Rong Mai
Wu-Qing Wan
Li-Bin Huang
Min-Cui Zheng
Chuan Tian
Hui-Qin Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.943761

2,331 views
4 citations

Review

Published on 09 Aug 2022

Maintenance therapy for AML after allogeneic HCT

in Hematologic Malignancies

Rahul K. Nayak
Yi-Bin Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.895771

7,474 views
6 citations

Brief Research Report

Published on 08 Aug 2022

Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition

in Hematologic Malignancies

Jan Vorwerk
Kaiyan Sun
Daria Frank
Felix Neumann
Jana Hüve
Paulina Marie Budde
Longlong Liu
Xiaoqing Xie
Pradeep Kumar Patnana
Helal Mohammed Mohammed Ahmed

Frontiers in Oncology

doi 10.3389/fonc.2022.903691

3,513 views
1 citation

Original Research

Published on 05 Aug 2022

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors

in Hematologic Malignancies

Manuela Mancini
Sara De Santis
Cecilia Monaldi
Fausto Castagnetti
Annalisa Lonetti
Samantha Bruno
Elisa Dan
Barbara Sinigaglia
Gianantonio Rosti
Michele Cavo

Frontiers in Oncology

doi 10.3389/fonc.2022.901132

2,630 views
4 citations

Brief Research Report

Published on 05 Aug 2022

Tumor-specific T cell-mediated upregulation of PD-L1 in myelodysplastic syndrome cells does not affect T-cell killing

in Hematologic Malignancies

Valentina Ferrari
Alison Tarke
Hannah Fields
Tiffany N. Tanaka
Stephen Searles
Maurizio Zanetti

Frontiers in Oncology

doi 10.3389/fonc.2022.915629

1,912 views
1 citation

Review

Published on 05 Aug 2022

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders

in Hematologic Malignancies

Argiris Symeonidis
Spiros Chondropoulos
Evgenia Verigou
Vasileios Lazaris
Alexandra Kourakli
Panagiotis Tsirigotis

Frontiers in Oncology

doi 10.3389/fonc.2022.884723

4,722 views
5 citations

Case Report

Published on 05 Aug 2022

Case Report: A rare case of small bowel obstruction secondary to plasma cell myeloma

in Hematologic Malignancies

Arturo Bonometti
Nicola Aronico
Giovanni Santacroce
Sara Fraticelli
Marco Lucioni
Claudio Salvatore Cartia
Alessandro Vanoli
Mario Andrea Latorre
Luca Arcaini
Marco Paulli

Frontiers in Oncology

doi 10.3389/fonc.2022.934566

1,995 views
1 citation

Original Research

Published on 05 Aug 2022

Long-term treatment outcome of Castleman’s disease: A real-world experience

in Hematologic Malignancies

Gi-June Min
Young-Woo Jeon
Tong Yoon Kim
Dae Hun Kwag
Jong Hyuk Lee
Joon Yeop Lee
Sung-Soo Park
Silvia Park
Jae-Ho Yoon
Sung-Eun Lee

Frontiers in Oncology

doi 10.3389/fonc.2022.974770

4,729 views
3 citations

Navigation group

Articles

Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis

Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia

Post-chemotherapy pneumonia in Chinese patients with diffuse large B-cell lymphoma: Outcomes and predictive model

Whole transcriptome sequencing reveals a TCF4-ZNF384 fusion in acute lymphoblastic leukemia

Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy

Small but strong: Pivotal roles and potential applications of snoRNAs in hematopoietic malignancies

Editorial: Global excellence in oncology: Asia and Australia 2021

Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: A report from the South China Children’s Leukemia Group

Maintenance therapy for AML after allogeneic HCT

Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors

Tumor-specific T cell-mediated upregulation of PD-L1 in myelodysplastic syndrome cells does not affect T-cell killing

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders

Case Report: A rare case of small bowel obstruction secondary to plasma cell myeloma

Long-term treatment outcome of Castleman’s disease: A real-world experience